G. Gardin

1.3k total citations
35 papers, 1.0k citations indexed

About

G. Gardin is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G. Gardin has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 22 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G. Gardin's work include Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (16 papers) and Estrogen and related hormone effects (8 papers). G. Gardin is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (16 papers) and Estrogen and related hormone effects (8 papers). G. Gardin collaborates with scholars based in Italy, United Kingdom and Ukraine. G. Gardin's co-authors include H.A. Chaudri, Geoffrey Falkson, Ulrike Hornberger, A. Fornasiero, Lawrence Panasci, A. Gudgeon, Myfanwy Morgan, Robert Leonard, P Dombernowsky and J Bellmunt and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of the New York Academy of Sciences.

In The Last Decade

G. Gardin

35 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Gardin Italy 12 635 591 451 234 160 35 1.0k
M. Azab United Kingdom 6 547 0.9× 303 0.5× 390 0.9× 228 1.0× 156 1.0× 7 845
Giorgio Mustacchi Italy 16 662 1.0× 587 1.0× 219 0.5× 221 0.9× 206 1.3× 64 1.0k
A McKinna United Kingdom 11 407 0.6× 232 0.4× 210 0.5× 125 0.5× 255 1.6× 14 756
G. Burton United States 10 879 1.4× 622 1.1× 924 2.0× 580 2.5× 243 1.5× 24 1.7k
S. Ashley United Kingdom 9 772 1.2× 432 0.7× 331 0.7× 133 0.6× 234 1.5× 12 1.1k
J.P. Lobelle Belgium 12 521 0.8× 343 0.6× 294 0.7× 117 0.5× 134 0.8× 25 794
Mauro Porpiglia Italy 11 456 0.7× 449 0.8× 564 1.3× 124 0.5× 97 0.6× 27 813
K.I. Pritchard Canada 15 682 1.1× 580 1.0× 183 0.4× 184 0.8× 182 1.1× 35 1.1k
G. Reiner Austria 21 742 1.2× 604 1.0× 329 0.7× 149 0.6× 272 1.7× 46 1.2k
R Pugh United States 9 739 1.2× 490 0.8× 254 0.6× 136 0.6× 299 1.9× 13 1.1k

Countries citing papers authored by G. Gardin

Since Specialization
Citations

This map shows the geographic impact of G. Gardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Gardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Gardin more than expected).

Fields of papers citing papers by G. Gardin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Gardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Gardin. The network helps show where G. Gardin may publish in the future.

Co-authorship network of co-authors of G. Gardin

This figure shows the co-authorship network connecting the top 25 collaborators of G. Gardin. A scholar is included among the top collaborators of G. Gardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Gardin. G. Gardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vinci, Angela Di, Ida Casciano, Elena Marasco, et al.. (2011). Quantitative methylation analysis of HOXA3, 7, 9, and 10 genes in glioma: association with tumor WHO grade and clinical outcome. Journal of Cancer Research and Clinical Oncology. 138(1). 35–47. 37 indexed citations
3.
Bedognetti, Davide, Mario Roberto Sertoli, P. Pronzato, et al.. (2011). Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial. JNCI Journal of the National Cancer Institute. 103(20). 1529–1539. 26 indexed citations
4.
Baldini, Editta, G. Gardin, Giuseppe Evangelista, et al.. (2004). Long-Term Results of Combined-Modality Therapy for Inflammatory Breast Carcinoma. Clinical Breast Cancer. 5(5). 358–363. 53 indexed citations
5.
Baldini, Editta, G. Gardin, Piergiorgio Giannessi, et al.. (2003). Accelerated versus standard cyclophosphamide, epirubicin and5-fluorouracil or cyclophosphamide, methotrexate and5-fluorouracil: a randomized phase III trial in locally advanced breast cancer. Annals of Oncology. 14(2). 227–232. 49 indexed citations
6.
Pronzato, P., Paola Queirolo, Rita Lionetto, et al.. (2000). Thymidine Labeling Index Analysis in Early Breast Cancer Patients Randomized to Receive Perioperative Chemotherapy. Oncology. 60(1). 88–93. 4 indexed citations
7.
Conté, Pierfranco, Editta Baldini, G. Gardin, et al.. (1996). Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO). Annals of Oncology. 7(5). 487–490. 9 indexed citations
8.
Gardin, G., R. Rosso, Elisabetta Campora, et al.. (1995). Locally advanced non-metastatic breast cancer: Analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach. European Journal of Cancer. 31(9). 1428–1433. 36 indexed citations
9.
Repetto, Lazzaro, Loredana Miglietta, G. Gardin, et al.. (1994). Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer. Breast Cancer Research and Treatment. 30(2). 133–137. 7 indexed citations
10.
Baldini, Editta, G. Gardin, P. Pronzato, et al.. (1993). Stimulation of Human Breast Cancer in Vivo. Annals of the New York Academy of Sciences. 698(1). 418–422. 3 indexed citations
11.
Rosso, R., G. Gardin, P. Pronzato, et al.. (1993). The Role of Lonidamine in the Treatment of Breast Cancer Patients. Annals of the New York Academy of Sciences. 698(1). 349–356. 2 indexed citations
12.
Merlini, Laura, et al.. (1993). Lymphoblastoid Interferon in Advanced Breast Cancer: a Phase II study. Journal of Chemotherapy. 5(4). 258–261. 2 indexed citations
13.
Repetto, Lazzaro, Loredana Miglietta, G. Gardin, et al.. (1992). Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer. Annals of Oncology. 3(2). 165–166. 6 indexed citations
14.
Miglietta, Loredana, Lazzaro Repetto, G. Gardin, et al.. (1991). Tamoxifen and Alpha Interferon in Advanced Breast Cancer. Journal of Chemotherapy. 3(6). 383–386. 7 indexed citations
15.
Pronzato, P., et al.. (1991). Oral Chemotherapy with Idarubicin plus Cyclophosphamide in Advanced Breast Cancer. Chemotherapy. 37(6). 449–453. 8 indexed citations
16.
Conté, Pierfranco, G. Gardin, P. Pronzato, et al.. (1990). In vivo manipulation of human breast cancer growth by estrogens and growth hormone: Kinetic and clinical results. The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 1103–1108. 9 indexed citations
17.
Canavese, Giuseppe, A. Catturich, C. Caroti, et al.. (1989). The Role of Surgery in the Combined Treatment of Locally Advanced Breast Cancer. Oncology. 46(6). 353–356. 5 indexed citations
18.
Merlano, Marco, R. Rosso, M. R. Sertoli, et al.. (1988). Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study.. Journal of Clinical Oncology. 6(4). 627–632. 32 indexed citations
19.
Lionetto, Rita, P. Pronzato, Pierfranco Conté, et al.. (1987). Multimodality Treatment of Locally Advanced Breast Cancer. Oncology. 44(3). 137–141. 7 indexed citations
20.
Conté, Pierfranco, Angela Alama, Gianfilippo Bertelli, et al.. (1987). Chemotherapy with estrogenic recruitment and surgery in locally advanced breast cancer: Clinical and cytokinetic results. International Journal of Cancer. 40(4). 490–494. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Azab Breakdown of academic impact, for papers by Giorgio Mustacchi Breakdown of academic impact, for papers by A McKinna Breakdown of academic impact, for papers by G. Burton Breakdown of academic impact, for papers by S. Ashley Breakdown of academic impact, for papers by J.P. Lobelle Breakdown of academic impact, for papers by Mauro Porpiglia Breakdown of academic impact, for papers by K.I. Pritchard Breakdown of academic impact, for papers by G. Reiner Breakdown of academic impact, for papers by R Pugh
Rankless by CCL
2026